| 000 | 03558nam a22005415i 4500 | ||
|---|---|---|---|
| 001 | 978-3-642-13185-1 | ||
| 003 | DE-He213 | ||
| 005 | 20140220084537.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100917s2010 gw | s |||| 0|eng d | ||
| 020 |
_a9783642131851 _9978-3-642-13185-1 |
||
| 024 | 7 |
_a10.1007/978-3-642-13185-1 _2doi |
|
| 050 | 4 | _aQD410-412.5 | |
| 072 | 7 |
_aPNND _2bicssc |
|
| 072 | 7 |
_aSCI013040 _2bisacsh |
|
| 082 | 0 | 4 |
_a547.05 _223 |
| 100 | 1 |
_aJaouen, Gérard. _eeditor. |
|
| 245 | 1 | 0 |
_aMedicinal Organometallic Chemistry _h[electronic resource] / _cedited by Gérard Jaouen, Nils Metzler-Nolte. |
| 264 | 1 |
_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg : _bImprint: Springer, _c2010. |
|
| 300 |
_aXVIII, 294 p. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aTopics in Organometallic Chemistry, _x1436-6002 ; _v32 |
|
| 505 | 0 | _aArsenic-Based Drugs: From Fowler’s Solution to Modern Anticancer Chemotherapy -- Activation Mechanisms for Organometallic Anticancer Complexes -- Organometallic Antitumour Agents with Alternative Modes of Action -- Ferrocene Functionalized Endocrine Modulators as Anticancer Agents -- Titanocenes: Cytotoxic and Anti-angiogenic Chemotherapy Against Advanced Renal-Cell Cancer -- Organometallics as Structural Scaffolds for Enzyme Inhibitor Design -- Bioorganometallic Chemistry and Malaria -- Biomedical Applications of Organometal–Peptide Conjugates -- Organometallic Radiopharmaceuticals -- Carbon Monoxide: An Essential Signalling Molecule. | |
| 520 | _aContents: Gérard Jaouen, Nils Metzler-Nolte : Introduction ; Stéphane GIBAUD and Gérard JAOUEN: Arsenic - based drugs: from Fowler’s solution to modern anticancer chemotherapy; Ana M. Pizarro, Abraha Habtemariam and Peter J. Sadler : Activation Mechanisms for Organometallic Anticancer Complexes; Angela Casini, Christian G. Hartinger, Alexey A. Nazarov, Paul J. Dyson : Organometallic antitumour agents with alternative modes of action; Elizabeth A. Hillard, Anne Vessières, Gerard Jaouen : Ferrocene functionalized endocrine modulators for the treatment of cancer; Megan Hogan and Matthias Tacke : Titanocenes – Cytotoxic and Anti-Angiogenic Chemotherapy Against Advanced Renal-Cell Cancer; Seann P. Mulcahy and Eric Meggers : Organometallics as Structural Scaffolds for Enzyme Inhibitor Design; Christophe Biot and Daniel Dive : Bioorganometallic Chemistry and Malaria; Nils Metzler-Nolte : Biomedical applications of organometal-peptide conjugates; Roger Alberto : Organometallic Radiopharmaceuticals; Brian E. Mann : Carbon Monoxide – an essential signaling molecule. | ||
| 650 | 0 | _aChemistry. | |
| 650 | 0 | _aOncology. | |
| 650 | 0 | _aPharmaceutical technology. | |
| 650 | 0 | _aBiochemical engineering. | |
| 650 | 0 | _aChemistry, Organic. | |
| 650 | 0 | _aBiochemistry. | |
| 650 | 1 | 4 | _aChemistry. |
| 650 | 2 | 4 | _aOrganometallic Chemistry. |
| 650 | 2 | 4 | _aMedicinal Chemistry. |
| 650 | 2 | 4 | _aCancer Research. |
| 650 | 2 | 4 | _aPharmaceutical Sciences/Technology. |
| 650 | 2 | 4 | _aBiochemical Engineering. |
| 700 | 1 |
_aMetzler-Nolte, Nils. _eeditor. |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783642131844 |
| 830 | 0 |
_aTopics in Organometallic Chemistry, _x1436-6002 ; _v32 |
|
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-3-642-13185-1 |
| 912 | _aZDB-2-CMS | ||
| 999 |
_c112203 _d112203 |
||